The structural correlates of functional deficits in early huntington's disease

Human Brain Mapping

Volumn 34, Issue 9, 2013, Pages 2141-2153

  Delmaire, Christine ^a,b   Dumas, Eve M ^c   Sharman, Michael A ^a   van den Bogaard, Simon J A ^c   Valabregue, Romain ^a   Jauffret, Céline ^a,d   Justo, Damian ^a,d   Reilmann, Ralf ^e   Stout, Julie C ^f   Craufurd, David ^g   Tabrizi, Sarah J ^h   Roos, Raymund A C ^c   Durr, Alexandra ^a,d   Lehéricy, Stéphane ^a,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diffusion tensor imaging; Huntington's disease; MRI; VBM

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; EXTERNAL CAPSULE; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HUNTINGTON CHOREA; IMAGE PROCESSING; INSULA; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER;

DIFFUSION TENSOR IMAGING; HUNTINGTON'S DISEASE; MRI; VBM;

APATHY; BRAIN; BRAIN MAPPING; COGNITION; COGNITION DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 84882667713     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22055     Document Type: Article

References (73)

1. Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, Bylsma FW, Pearlson GD, Ross CA (1997): Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 48:394-399.
2. Backman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L (1997): Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 120 (Part 12):2207-2217.
3. Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J (2007): Olfaction and neurodegeneration in HD. Neuroreport 18:73-76.
4. Basser PJ, Pierpaoli C (1996): Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111:209-219.
5. Basser PJ, Pierpaoli C (1998): A simplified method to measure the diffusion tensor from seven MR images. Magn Reson Med 39:928-934.
6. Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, Langbehn DR, Stout JC, Tabrizi SJ, Reilmann R (2010): Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology 75:2150-2160.
7. Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS (2009): Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study. Mov Disord 24:1763-1772.
8. Bylsma FW, Moberg PJ, Doty RL, Brandt J (1997): Odor identification in Huntington's disease patients and asymptomatic gene carriers. J Neuropsychiatry Clin Neurosci 9:598-600.
9. Craufurd D, Thompson JC, Snowden JS (2001): Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 14:219-226.
10. Crowe SF (1998): The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance on parts A and B of the trail making test. J Clin Psychol 54:585-591.
11. Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Levi AC, Hantraye P, Remy P (2009): In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 46:958-966.
12. Elliott R, Newman JL, Longe OA, Deakin JF (2003): Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: A parametric functional magnetic resonance imaging study. J Neurosci 23:303-307.
13. Friston KJ (1997): Testing for anatomically specified regional effects. Hum Brain Mapp 5:133-136.
14. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E (1998): Regional specificity of brain atrophy in Huntington's disease. Exp Neurol 154:663-672.
15. Hamilton JM, Murphy C, Paulsen JS (1999): Odor detection, learning, and memory in Huntington's disease. J Int Neuropsychol Soc 5:609-615.
16. Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, Gotz M (1994): Cortical and striatal neurone number in Huntington's disease. Acta Neuropathol 88:320-333.
17. Henley SM, Wild EJ, Hobbs NZ, Warren JD, Frost C, Scahill RI, Ridgway GR, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. (2008): Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia 46:2152-2160.
18. Henley SM, Wild EJ, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ (2009): Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov Disord 24:932-936.
19. Hickok G, Erhard P, Kassubek J, Helms-Tillery AK, Naeve-Velguth S, Strupp JP, Strick PL, Ugurbil K (2000): A functional magnetic resonance imaging study of the role of left posterior superior temporal gyrus in speech production: Implications for the explanation of conduction aphasia. Neurosci Lett 287:156-160.
20. Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ (2009): The progression of regional atrophy in premanifest and early Huntington's disease: A longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry 81:756-763.
21. Huntington Study Group (1996): Unified Huntington's disease rating scale: Reliability and consistency. Mov Disord 11:136-142.
22. Jantzen KJ, Steinberg FL, Kelso JA (2004): Brain networks underlying human timing behavior are influenced by prior context. Proc Natl Acad Sci USA 101:6815-6820.
23. Jantzen KJ, Steinberg FL, Kelso JA (2005): Functional MRI reveals the existence of modality and coordination-dependent timing networks. Neuroimage 25:1031-1042.
24. Jenkins IH, Jahanshahi M, Jueptner M, Passingham RE, Brooks DJ (2000): Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain 123 (Part 6):1216-1228.
25. Kareken DA, Mosnik DM, Doty RL, Dzemidzic M, Hutchins GD (2003): Functional anatomy of human odor sensation, discrimination, and identification in health and aging. Neuropsychology 17:482-495.
26. Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RA (2008): Behavioral problems in Huntington's disease using the problem behaviors assessment. Gen Hosp Psychiatry 30:155-161.
27. Klöppel S, Draganski B, Golding CV, Chu C, Nagy Z, Cook PA, Hicks SL, Kennard C, Alexander DC, Parker GJ, Tabrizi SJ, Frackowiak RS (2008): White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 131 (Part 1):196-204.
28. Le Bihan D, Jezzard P, Haxby J, Sadato N, Rueckert L, Mattay V (1995): Functional magnetic resonance imaging of the brain. Ann Intern Med 122:296-303.
29. Lehericy S, Bardinet E, Tremblay L, Van de Moortele PF, Pochon JB, Dormont D, Kim DS, Yelnik J, Ugurbil K (2006): Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb Cortex 16:149-161.
30. Levy R, Dubois B (2006): Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 16:916-928.
31. Lewis PA, Wing AM, Pope PA, Praamstra P, Miall RC (2004): Brain activity correlates differentially with increasing temporal complexity of rhythms during initialization, synchronization, and continuation phases of paced finger tapping. Neuropsychologia 42:1301-1312.
32. Li H, Li SH, Yu ZX, Shelbourne P, Li XJ (2001): Huntington aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J Neurosci 21:8473-8481.
33. Macdonald V, Halliday G (2002): Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol Dis 10:378-386.
34. Mangin JF, Poupon C, Clark C, Le Bihan D, Bloch I (2002): Distortion correction and robust tensor estimation for MR diffusion imaging. Med Image Anal 6:191-198.
35. Mann DM, Oliver R, Snowden JS (1993): The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol 85:553-559.
36. Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, Politi LS, Macucci M, Filippi M, Piacentini S (2004): Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 232:867-873.
37. Michell AW, Goodman AO, Silva AH, Lazic SE, Morton AJ, Barker RA (2008): Hand tapping: A simple, reproducible, objective marker of motor dysfunction in Huntington's disease. J Neurol 255:1145-1152.
38. Moberg PJ, Doty RL (1997): Olfactory function in Huntington's disease patients and at-risk offspring. Int J Neurosci 89:133-139.
39. Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, Tsuruda J, Norman D (1990): Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 176:439-445.
40. Nordin S, Paulsen JS, Murphy C (1995): Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc 1:281-290.
41. Ongur D, Ferry AT, Price JL (2003): Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 460:425-449.
42. Penhune VB, Zattore RJ, Evans AC (1998): Cerebellar contributions to motor timing: A PET study of auditory and visual rhythm reproduction. J Cogn Neurosci 10:752-765.
43. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997): CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41:689-692.
44. Perry ME, McDonald CR, Hagler DJ Jr, Gharapetian L, Kuperman JM, Koyama AK, Dale AM, McEvoy LK (2009): White matter tracts associated with set-shifting in healthy aging. Neuropsychologia 47:2835-2842.
45. Pierpaoli C, Basser PJ (1996): Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 36:893-906.
46. Reading SA, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL, Aylward EH, Brandt J, Mori S, van Zijl P, Bassett SS, Ross CA (2005): Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study. Psychiatry Res 140:55-62.
47. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B (2002): Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58:695-701.
48. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B (2005): Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745-747.
49. Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH (2006): Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 21:1317-1325.
50. Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM (2008): Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain 131 (Part 4):1057-1068.
51. Rosas HD, Lee SY, Bender AC, Zaleta AK, Vangel M, Yu P, Fischl B, Pappu V, Onorato C, Cha JH, Salat DH, Hersch SM. (2010): Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection." Neuroimage 49:2995-3004.
52. Rowe KC, Paulsen JS, Langbehn DR, Duff K, Beglinger LJ, Wang C, O'Rourke JJ, Stout JC, Moser DJ (2010): Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology 24:435-442.
53. Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997): Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 42:604-612.
54. Sapp E, Penney J, Young A, Aronin N, Vonsattel JP, DiFiglia M (1999): Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58:165-173.
55. Savic I, Gulyas B, Larsson M, Roland P (2000): Olfactory functions are mediated by parallel and hierarchical processing. Neuron 26:735-745.
56. Selemon LD, Rajkowska G, Goldman-Rakic PS (2004): Evidence for progression in frontal cortical pathology in late-stage Huntington's disease. J Comp Neurol 468:190-204.
57. Smith A (1991): Symbol Digit Modalities Test. Los Angeles: Western Psychological Services.
58. Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C, Frati L, Ciarmiello A (2009): Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease. CNS Neurosci Ther 15:1-11.
59. Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR (2010): Contrasting gray and white matter changes in preclinical Huntington disease: An MRI study. Neurology 74:1208-1216.
60. Stroop JR (1935): Studies on interference in serial verbal reactions. J Exp Psychol 18:643-662.
61. Stuss DT, Bisschop SM, Alexander MP, Levine B, Katz D, Izukawa D (2001): The trail making test: A study in focal lesion patients. Psychol Assess 13:230-239.
62. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC; TRACK-HD investigators (2009): Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol 8:791-801.
63. Thompson JC, Snowden JS, Craufurd D, Neary D (2002): Behavior in Huntington's disease: Dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 14:37-43.
64. Tremblay L, Schultz W (1999): Relative reward preference in primate orbitofrontal cortex. Nature 398:704-708.
65. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002): Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289.
66. Vonsattel JP (2008): Huntington disease models and human neuropathology: Similarities and differences. Acta Neuropathol 115:55-69.
67. Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH (2009): Longitudinal diffusion tensor imaging in Huntington's Disease. Exp Neurol 216:525-529.
68. Witt ST, Laird AR, Meyerand ME (2008): Functional neuroimaging correlates of finger-tapping task variations: An ALE meta-analysis. Neuroimage 42:343-356.
69. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996): A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:58-73.
70. Wu T, Hallett M (2005): A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 128 (Part 10):2250-2259.
71. Wu T, Kansaku K, Hallett M (2004): How self-initiated memorized movements become automatic: A functional MRI study. J Neurophysiol 91:1690-1698.
72. Zakzanis KK, Mraz R, Graham SJ (2005): An fMRI study of the trail making test. Neuropsychologia 43:1878-1886.
73. Zimbelman JL, Paulsen JS, Mikos A, Reynolds NC, Hoffmann RG, Rao SM (2007): fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 13:758-769.